Angle, Abbott Ink Deal for Use of FISH With Harvested CTCs

Feb 06, 2018

|

NEW YORK (GenomeWeb) – Angle said today that Abbott will supply PathVysion HER-2 DNA FISH kits for a study aimed at investigating analysis of circulating tumor cells.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Angle, Abbott Ink Deal for Use of FISH With Harvested CTCs

To read the full story....

Breaking News

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Todos Medical Obtains $3.4M Investment From Yozma Group Korea

Infectious Disease Test Firm Talis Biomedical Files for IPO

Roche Renews Agreement to Distribute Sysmex Hematology Products

Featured White Papers

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

What's Popular?

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Infectious Disease Test Firm Talis Biomedical Files for IPO

NASA Looking to Spin Out Breath Analysis Platform for Use in Diagnostics Applications

Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

NeoGenomics to Grow Pharma, Informatics Divisions Through CDx Agreements, Acquisitions

Sponsorships